GlassScriptPhysician profile
Ythan Wye Webster
NPI 1588084982
$9,607.04
in general payments reported to CMS, 2019-2025
34 companies · $579 in 2025
The $579 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,305 · 2020: $80.03 · 2021: $1,370 · 2022: $89.78 · 2023: $2,789 · 2024: $394 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,902 · Travel and Lodging: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,901.72 |
| Travel and Lodging | $860.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,970.17 | 2019-2023 | |
| Stryker Corporation | $1,058.11 | 2021 | |
| Paragon 28, INC. | $1,024.17 | 2019-2024 | Smart Lapidus |
| Tricoast Surgical Solutions LLC | $765.31 | 2023-2024 | |
| Smith+Nephew, INC. | $275.70 | 2021-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Epsfl, LLC | $217.44 | 2023 | |
| Osiris Therapeutics INC. | $200.11 | 2019 | |
| Orthofix Medical, INC. | $194.15 | 2019-2020 | |
| Amgen INC. | $190.35 | 2024-2025 | Krystexxa |
| Biotissue Holdings INC. | $183.92 | 2021 | |
| Abbvie INC. | $164.48 | 2023-2025 | Dalvance |
| Bioventus LLC | $153.61 | 2023-2025 | Theragenesis Bilayer Wound Matrix, Exogen Ultrasound Bone Healing System, Sonicone Clinic |
| Imbed Biosciences INC. | $146.19 | 2023 | |
| Medtronic, INC. | $145.94 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Organogenesis INC. | $139.05 | 2023-2025 | Puraply Antimicrobial, Simplimax |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $112.22 | 2019-2024 | Minibunion, Na, Motoband |
| Solventum Corporation | $106.90 | 2024-2025 | Activ.A.C., 3m Coban, Kerramax Care |
| Globus Medical, INC. | $64.46 | 2025 | Senza |
| Nevro Corp. | $59.74 | 2023-2024 | Senza |
| Mimedx Group, INC. | $57.91 | 2024-2025 | |
| Kci USA, INC. | $52.56 | 2019 | |
| Misonix INC | $50.69 | 2021 | |
| Next Science LLC | $45.23 | 2023 | Xperience, Blastx, Surgx |
| Biocomposites INC | $31.78 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $31.40 | 2021 | |
| Horizon Therapeutics Plc | $29.13 | 2023 | Krystexxa |
| Aroa Biosurgery Incorporated | $28.20 | 2025 | |
| Advanced Oxygen Therapy INC. | $17.28 | 2025 | Topical Oxygen Chamber For Extremities |
| Zimvie INC. | $17.22 | 2023 | |
| Lifenet Health | $16.69 | 2024 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $16.04 | 2022 | |
| Treace Medical Concepts, INC. | $14.45 | 2025 | |
| Sebela Pharmaceuticals INC. | $13.67 | 2023 | Naftin |
| Kowa Pharmaceuticals America, INC. | $12.77 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ythan Webster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.